-
Taxonomy & unit
-
ratio: %
-
Description
-
Return on assets can be defined as an indicator of how profitable a company is relative to its total assets. Calculated by dividing a company's operating earnings by its total assets.
-
Summary
-
Sonnet BioTherapeutics Holdings, Inc. quarterly/annual Return On Assets history and growth rate from 2012 to 2024.
- Sonnet BioTherapeutics Holdings, Inc. Return On Assets for the quarter ending December 31, 2024 was -174 %, a 2.71% decline year-over-year.
- Sonnet BioTherapeutics Holdings, Inc. annual Return On Assets for 2024 was -150 %, a 32.8% increase from 2023.
- Sonnet BioTherapeutics Holdings, Inc. annual Return On Assets for 2023 was -223 %, a 7.72% increase from 2022.
- Sonnet BioTherapeutics Holdings, Inc. annual Return On Assets for 2022 was -242 %, a 13.4% decline from 2021.
Return On Assets, Annual (%)
Return On Assets, YoY Annual Growth (%)